▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Microvision Q2 21 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 8/4/2021 3:00 PM ET

Microvision Inc. (MVIS) will host a conference call at 5:00 PM ET on August 4, 2021, to discuss Q2 21 earnings results.

To access the live webcast, log on to https://ir.microvision.com/news-events/ir-calendar

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

184K New Covid Cases, 860 Deaths In U.S.

50K New Covid Cases, 80 Deaths In U.S.

Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial

FDA Advisers Recommend Pfizer, Moderna COVID-19 Vaccines For Kids As Young As 6 Months

FDA Advisers Recommend Moderna Covid-19 Vaccine For Ages 6 To 17

Read More

COVID-19: Drugs in Development

RELATED NEWS

Microvision Inc. Q1 Loss increases, misses estimates

Microvision Q1 22 Earnings Conference Call At 5:00 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Flight Cancellations, Delays On The Rise In US

FSIS Warns Against Ineligible Siluriformes Products Imported From Korea

Panera At Home Southwest Corn Chowder Recalled

MTD Products Recalls Walk-Behind Self-Propelled Lawn Mowers

Nike To Fully Exit Russia As Ukraine Invasion Continues

FDA Action Plan To Speed Up Drug Development For Rare Neurodegenerative Diseases

Loctek Recalls Fleximouts Overhead Garage Storage Racks

US To Import Millions Of Infant Formula Bottles From UK, Australia, Mexico

CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Recalled

FDA Probes Death Of Infant Who Consumed Abbott Infant Formula

Lowe's Opens 3D Product Library To Help Builders

CVS Health's Free Health Screening Program Expanded To New Areas

CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Recalled

Toyota Recalls BZ4X Electric SUVs

Ex-Tesla Workers Sue Elon Musk Over Unlawful Termination

Biocartis In Deal With AstraZeneca To Develop Companion Diagnostic Test For Tagrisso

Novavax COVID-19 Vaccine Recommended For Conditional Marketing Authorization In EU For Adolescents

Clariant To Reorganize In Three Global Business Units Instead Of Five Units

Elon Musk Says Tesla's Berlin, Texas Factories Are 'gigantic Money Furnaces'

FDA Action Plan To Speed Up Drug Development For Rare Neurodegenerative Diseases

FedEx Corporation Q4 Profit Decreases, misses estimates

NTLA : Study Of NTLA-2001 On Transthyretin Amyloidosis Shows Serum TTR Reductions Remained Durable

AstraZeneca: Phase III Data Show Significant Copper Mobilization From Tissues With ALXN1840

Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial

Empire Company Q4 Profit Climbs, But Misses Estimates - Update

Lamprell Receives Indicative Cash Offer From Blofeld

BioNTech Begins Construction Of First MRNA Vaccine Production Site In Africa

McDonald's Appoints Ian Borden To Succeed Kevin Ozan As CFO

Keller Group Sees Full-year Performance Inline, Bags Order From S.Arabia 's NEOM Giga Project

Westwater Resources Names Steven Cates CFO, Vice President - Finance, Effective Aug. 26

NTLA : Study Of NTLA-2001 On Transthyretin Amyloidosis Shows Serum TTR Reductions Remained Durable

Li Auto Says Orders For Newly Launched SUV Li L9 Crossed 30K Mark In 3 Days; Stocks Up In Pre-market

Basilea' Partner Pfizer Gets Approval In China For Addl Formulation Of Antifungal Cresemba In China

Ascletis' ASC22 Shows Potential Of Functional Cure Of Chronic Hepatitis B In Phase IIb Trial

Carlsberg CFO Heine Dalsgaard Resigns

FedEx Corporation Q4 Profit Decreases, misses estimates